Zobrazeno 1 - 10
of 151
pro vyhledávání: '"primary poor graft function"'
Autor:
Liu, Jing1 (AUTHOR), Zhao, Xiang‐Yu1 (AUTHOR), Xu, Lan‐Ping1 (AUTHOR), Zhang, Xiao‐Hui1 (AUTHOR), Wang, Yu1 (AUTHOR), Mo, Xiao‐Dong1 (AUTHOR), Zhang, Yuan‐Yuan1 (AUTHOR), Zhao, Xiao‐Su1 (AUTHOR), Cheng, Yi‐Fei1 (AUTHOR), Liu, Kai‐Yan1 (AUTHOR), Huang, Xiao‐Jun1,2,3 (AUTHOR), Chang, Ying‐Jun1 (AUTHOR) rmcyj@bjmu.edu.cn
Publikováno v:
HLA: Immune Response Genetics. Jan2024, Vol. 103 Issue 1, p1-10. 10p.
Publikováno v:
In Biology of Blood and Marrow Transplantation September 2019 25(9):1898-1907
Autor:
Lin-Yi ZHANG, Yi-Ying XIONG, Ming-Yan LIAO, XIAO Qing, Xiao-Qiong TANG, LUO Xiao-Hua, Hong-Bin ZHANG, WANG Li, LIU Lin
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapy but can result in significant complications including poor graft function (PGF). Little is known about the risk factors of primary PGF occurring after allo-HSCT. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33871b769ad7729e8d0c415b53f21e2b
https://doi.org/10.21203/rs.3.rs-1981425/v1
https://doi.org/10.21203/rs.3.rs-1981425/v1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 25(9)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapy for both malignant and nonmalignant hematologic disorders. However, primary poor graft function (PGF) is a serious early complication of allo-HSCT that leads to a po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae3b48b3dfcdd8359e384df0c35ef791
https://pubmed.ncbi.nlm.nih.gov/31176790
https://pubmed.ncbi.nlm.nih.gov/31176790
Autor:
Wei Han, Feng-Rong Wang, Lan-Ping Xu, Xiao-Hui Zhang, Jing-Zhi Wang, Yu-Qian Sun, Gan-Lin He, Xiao-Jun Huang, Yu-Hong Chen, Huan Chen, Yu Wang, Ying-Jun Chang, Kai-Yan Liu
Publikováno v:
Annals of Hematology. 94:1699-1705
Primary poor graft function (PGF) is a severe complication after allogeneic stem cell transplantation (SCT). The incidence, risk factors, and outcomes of PGF have not been well described, especially in the haploidentical SCT setting. We retrospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::950cf277def5425f885cc7fe8087b316
https://doi.org/10.1007/s00277-015-2440-x
https://doi.org/10.1007/s00277-015-2440-x
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Oncology & Therapy; Sep2024, Vol. 12 Issue 3, p375-394, 20p
Publikováno v:
Chinese Journal of Hematology
目的 研究单倍型造血干细胞移植（haplo-HSCT）后原发性植入功能不良（PGF）对巨细胞病毒（CMV）肺炎发生及预后的影响。 方法 对2011年1月至2012年12月在北京大学血液病研究所接受haplo-HSCT的122
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f817ec93f8e7788882b265930ee3d013
http://europepmc.org/articles/PMC7449765
http://europepmc.org/articles/PMC7449765